mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R)
Latest Information Update: 07 Mar 2024
At a glance
- Drugs Baricitinib (Primary) ; Ravulizumab (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- Acronyms TACTIC-R; TACTIC-R (COVID-19)
- 07 Sep 2021 Status changed from active, no longer recruiting to completed.
- 20 May 2020 New trial record